Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials

Table 2 Unit Cost Sources for Economic Evaluation

Measure	Utilization data source	Unit cost source–policymaker perspective	Unit cost source–societal perspective
*Substance use disorder therapy*
XR-NTX	Study documents & NMOS	T-MSIS + dispensing fee estimated via DATCAP	FSS + dispensing fee estimated via DATCAP
Methadone and buprenorphine	NMOS	T-MSIS	FSS
Behavioral therapy	NMOS	T-MSIS	Medicare FFS
Inpatient detoxification	NMOS	T-MSIS	Medicare FFS
Residential treatment	NMOS	T-MSIS	Medicare FFS
*Other healthcare services*
Hospital stays	NMOS	T-MSIS	Medicare FFS
Outpatient visits	NMOS	T-MSIS	Medicare FFS
Emergency department visits	NMOS	T-MSIS	Medicare FFS
Mental health visits	NMOS	T-MSIS	Medicare FFS
Other prescriptions	NMOS	T-MSIS	FSS
*Criminal justice activities*
Specific crimes	Criminal records & CLAF	McCollister et al. (2010): direct costs	McCollister et al. (2010): societal costs
Probation visits	CLAF	BLS	BLS
*Other resources*
Work	NMOS	N/A	Self-reported wages & hours worked
Education	NMOS	N/A	Self-reported time in school & Card (1999) estimates
Participant time	NMOS	N/A	Self-reported or federal minimum wage
Participant travel	Site visit	N/A	Area public transportation fees & IRS mileage rates

NMOS Non-study Medical and Other Services form, T-MSIS Transformed Medicaid Statistical Information System, DATCAP Drug Abuse Treatment Cost Analysis Program instrument, FSS Department of Veterans Affairs Federal Supply Schedule, CLAF Criminal and Legal Activities Form, Medicare FFS Medicare fee-for-service

ISSN: 1940-0640